北交所:保障疫情影響嚴重地區和行業企業的審覈工作正常推進
格隆匯5月31日丨北交所發佈關於進一步優化監管服務,支持受疫情影響嚴重地區和行業恢復發展若幹措施的通知。其中提到,保障疫情影響嚴重地區和行業企業的審覈工作正常推進。2022年年底前,對受疫情影響嚴重地區和行業的企業,保薦機構無法在申報前完成客戶或供應商實地走訪工作的,在符合盡職調查規則要求的前提下,可以正常申報,在落實問詢意見期間完善相關覈查工作。2022年業績受疫情影響下滑的,在符合《北京證券交易所向不特定合格投資者公開發行股票並上市業務規則適用指引第1號》1-15經營業績大幅下滑的相關規定,且充分揭示風險的前提下,相關審覈工作正常推進。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.